Dark

Check out our Dark Pool Levels

ARTH
ARCH THERAPEUTICS INC
stock OTC

Inactive

Apr 21, 2025

0.1608USD-19.600%(-0.0392)269

Pre-market

0.00USD-100.000%(-0.20)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 6, 2022

07:50AM EST Clinical Evaluation Finds Arch Therapeutics GlobeNewswire Inc

Jan 4, 2022

09:48AM EST Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced the appointment of Guy Fish, M.D. to its Board of Directors. GlobeNewswire Inc

Dec 13, 2021

07:50AM EST Arch Therapeutics Granted Federal Supply Schedule and General GlobeNewswire Inc

Dec 1, 2021

07:50AM EST Renowned Expert Dr. Christopher Gauland Shares Insights on Treating DFUs and Success with AC5 Advanced Wound System GlobeNewswire Inc

Nov 1, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), a marketer and developer of novel self-assembling wound care and biosurgical devices, presented at the Symposium on Advanced Wound Care (SAWC) during the Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care session on October 31, 2021. GlobeNewswire Inc

Oct 25, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced that it will be presenting at the 2021 Symposium on Advanced Wound Care(SAWC)Fall. The event is being held at Caesars Palace,Las Vegas, NevadafromOctober 29-31, 2021. GlobeNewswire Inc

Oct 18, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), a marketer and developer of novel self-assembling wound care and biosurgical devices, announced today that it has launched its Experts in Wound Care Program, a series of interviews with key opinion leaders dedicated to advancing wound care. GlobeNewswire Inc

Oct 13, 2021

04:30PM EDT 90-Day Report Card for Commercialization Effort GlobeNewswire Inc

Oct 6, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), a marketer and developer of novel self-assembling wound care and biosurgical devices, will be featured as a presenting company at the LD Micro Main Event XIV. The conference is being held October 12th - 14th, 2021 at the Luxe Sunset Boulevard Hotel, Los Angeles, CA. GlobeNewswire Inc

Oct 4, 2021

07:50AM EDT Arch Therapeutics Launches Coverage and Reimbursement Pilot GlobeNewswire Inc

Sep 30, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced the appointment of Larry Hicks to its Board of Directors. GlobeNewswire Inc

Sep 2, 2021

07:00AM EDT Arch Therapeutics Partners with Lovell Government Services to GlobeNewswire Inc

Jul 12, 2021

07:50AM EDT Medical Industry Veteran with Proven Track Record to Drive Commercialization Effort GlobeNewswire Inc

Jul 7, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), developer of novel self-assembling wound care and biosurgical devices, today announced that it will present at the upcoming Ladenburg Thalmann 2021 Healthcare Conference, which shall be held July 13-14, 2021. GlobeNewswire Inc

Jun 2, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), developer of novel self-assembling wound care and biosurgical devices, today announced that it will be presented virtually at the upcoming LD Micro Invitational XI event. GlobeNewswire Inc

May 10, 2021

07:50AM EDT Arch Therapeutics AC5 Advanced Wound GlobeNewswire Inc

May 3, 2021

07:50AM EDT Arch Therapeutics Appoints Michael S. Abrams its Chief Financial GlobeNewswire Inc

Apr 27, 2021

07:50AM EDT Arch Therapeutics to Present AC5 Advanced Wound System GlobeNewswire Inc

Apr 19, 2021

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Company), developer of novel self-assembling wound care and biosurgical devices, today provided the following corporate update, in line with its commitment to maintain continuing dialogue with investors and other stakeholders on the progress and development of the Company. GlobeNewswire Inc

Mar 2, 2021

07:50AM EST Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), innovator of AC5 Advanced Wound System and other self-assembling Dermal Sciences and BioSurgery devices, announced today that it will be presenting at the H.C. Wainwright Global Life Sciences Conference, which will be held March 9-10, 2021. GlobeNewswire Inc

Feb 18, 2021

07:50AM EST Arch Therapeutics Announces Closing of $6.9 Million Private Placement GlobeNewswire Inc

Feb 12, 2021

12:45AM EST Arch Therapeutics Announces $6.9 Million Private Placement GlobeNewswire Inc

Jan 5, 2021

07:56AM EST Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021. GlobeNewswire Inc

Jan 4, 2021

07:50AM EST Arch Therapeutics Announces Distribution Agreement with Buffalo GlobeNewswire Inc

Dec 11, 2020

07:50AM EST Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the 13th annual LD Micro Main Event investor conference. This investor conference will take place December 14-15, 2020, on the Sequire Virtual Events platform. GlobeNewswire Inc

Nov 10, 2020

07:50AM EST Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announces that it has raised approximately $1.1M from long-term shareholders. GlobeNewswire Inc

Nov 9, 2020

07:50AM EST Arch Therapeutics AC5 Advanced Wound System GlobeNewswire Inc

Oct 22, 2020

07:50AM EDT Arch Therapeutics, Inc. (OTCQB:ARTH) (Arch or the Company), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that management and key opinion leaders will discuss AC5 Advanced Wound System in the Virtual Investor KOL Roundtable on Wednesday, October 28, 2020 at 12:00 PM ET. GlobeNewswire Inc

Oct 14, 2020

07:50AM EDT Arch Therapeutics Announces Presentations on AC5 Advanced Wound GlobeNewswire Inc

Aug 26, 2020

07:50AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that Terrence W. Norchi, MD, Chief Executive Officer, will present at the LD 500 Virtual Conference on Tuesday, September 1st, 2020 at 1:00 PM ET. The conference is being held on September 1-4, 2020. GlobeNewswire Inc

Aug 11, 2020

08:01AM EDT Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, announces the release of research from the AC5 self-assembling peptide technology platform that was presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting. GlobeNewswire Inc

Aug 7, 2020

09:23AM EDT Arch Therapeutics Novel Self-Assembling Agent for Use in GlobeNewswire Inc

Jul 27, 2020

06:45AM EDT HC Wainwright & Co. Maintains Buy on Arch Therapeutics, Lowers Price Target to $1.5 Benzinga

Share